Effect of recombinant human growth hormone on liver fat content in young adults with nonalcoholic fatty liver disease-Reference-Cited by-同舟云学术

Effect of recombinant human growth hormone on liver fat content in young adults with nonalcoholic fatty liver disease

Published:2020-10-10 Issue:2 Volume:94 Page:183-192
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Pan Chelsea S.¹,Weiss Julian J.¹²,Fourman Lindsay T.¹,Buckless Colleen³,Branch Karen L.⁴,Lee Hang⁵,Torriani Martin³,Misra Madhusmita⁶⁷,Stanley Takara L.¹⁶^ORCID

Affiliation:

1. Metabolism Unit Massachusetts General Hospital and Harvard Medical School Boston MA USA

2. Yale School of Medicine New Haven CT USA

3. Department of Radiology Massachusetts General Hospital and Harvard Medical School Boston MA USA

4. Translational and Clinical Research Center Massachusetts General Hospital Boston MA USA

5. Biostatistics Unit Massachusetts General Hospital and Harvard Medical School Boston MA USA

6. Pediatric Endocrine Division Massachusetts General Hospital and Harvard Medical School Boston MA USA

7. Neuroendocrine Unit Massachusetts General Hospital and Harvard Medical School Boston MA USA

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

Eunice Kennedy Shriver National Institute of Child Health and Human Development

Novo Nordisk

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cen.14344

Reference50 articles.

1. Increasing Prevalence of Nonalcoholic Fatty Liver Disease Among United States Adolescents, 1988-1994 to 2007-2010

2. Increasing Burden of Chronic Liver Disease Among Adolescents and Young Adults in the USA: A Silent Epidemic

3. Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges

4. NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN)

5. Prevalence of Fatty Liver in Children and Adolescents

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Growth hormone augmentation in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials;European Journal of Gastroenterology & Hepatology;2024-07-08

2. Role of Growth Hormone Therapy in Metabolic-Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis;Indian Journal of Endocrinology and Metabolism;2024-07

3. Metabolic-associated fatty liver disease and the role of hormones in its aetiopathogenesis;Endokrynologia Polska;2024-06-26

4. Growth hormone in pediatric chronic kidney disease: more than just height;Pediatric Nephrology;2024-04-12

5. From liver to hormones: The endocrine consequences of cirrhosis;World Journal of Gastroenterology;2024-03-07